ACET
Adicet Bio Inc
6.50$
-2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.37 | 16.48 | -11.24 | 9.84 | 9.05 | 15.81 | 16.97 | 16.04 | 4.76 | -6.85 | -9.76 | -24.04 | -90.82 | -26.39 | -17.44 | -34.84 | -16.82 | -13.82 | |
| 1.75 | 1.37 | 2.03 | 3.86 | 4.73 | 4.63 | 4.63 | 5.18 | 6.76 | 0.00 | 0.66 | 1.07 | 2.68 | 0.80 | 1.00 | 2.27 | 1.18 | 0.33 | |
| 0.95 | 1.14 | 0.76 | 0.60 | 0.80 | 1.19 | 1.19 | 2.02 | 2.59 | 0.28 | 1.33 | 1.01 | 11.50 | 6.47 | 6.67 | 7.53 | 4.05 | 2.07 | |
| 89.56 | 105.94 | -2.96 | -2.65 | -3.75 | 1.93 | 6.70 | 18.85 | 15.68 | 2.53 | -4.32 | 0.29 | -29.56 | -3.13 | 1.07 | 0.09 | -1.01 | 0.21 | |
| 0.88 | 0.41 | 2.87 | 3.80 | 0.75 | 0.68 | 0.68 | 0.73 | 0.35 | 0.03 | 0.47 | 0.92 | 2.16 | 6.74 | 6.54 | 1.66 | 0.20 | 0.25 | |
| 1.04 | -2.97 | -4.43 | -48.49 | -1.21 | -0.70 | -1.87 | -55.01 | -5.12 | -0.03 | -8.62 | -41.32 | 251.84 | -1.45 | -6.54 | -1.66 | -21.71 | 0.35 | |
| – | 3.62 | 3.67 | 3.65 | 3.64 | 4.01 | 4.01 | 4.36 | 3.97 | 4.20 | – | – | – | – | – | – | – | – | |
| – | – | – | – | -16.96 | -22.14 | -28.58 | -21.78 | -38.12 | -33.03 | – | – | – | – | -1.26 | -0.06 | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00 | -0.02 | |
| -4.45 | -3.12 | -1.77 | 35.01 | -10.43 | -9.53 | -9.53 | 45.15 | -4.70 | 38.52 | 5.93 | 66.34 | 0.66 | 125.45 | 16.17 | 0.09 | 20.27 | 10.92 | |
| 10.47 | 8.23 | -19.51 | -1.53 | -2.59 | 5.57 | 5.57 | 6.19 | -5.06 | 18.08 | -12.45 | 0.98 | 161.68 | 97.61 | -7.80 | -36.41 | -18.27 | -2.56 | |
| 10.49 | 16.07 | -14.11 | 6.03 | 8.30 | 15.13 | 16.29 | 15.31 | 4.41 | -6.88 | -10.23 | -24.96 | -92.99 | -33.13 | -23.97 | -36.50 | -17.03 | -14.07 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.